Offer - Urjas Oil for just ₹ 1 X
Doxomit OD is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Doxomit OD safe for pregnant women?
Doxomit OD is safe for pregnant women.
Is the use of Doxomit OD safe during breastfeeding?
Doxomit OD does not show any side effects in breastfeeding women.
What is the effect of Doxomit OD on the Kidneys?
Doxomit OD is completely safe for kidneys.
What is the effect of Doxomit OD on the Liver?
There are no any side effects of Doxomit OD on the liver.
What is the effect of Doxomit OD on the Heart?
Doxomit OD is completely safe for the heart.
Doxomit OD should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Doxomit OD unless your doctor advises you to do so -
Is this Doxomit OD habit forming or addictive?
Doxomit OD does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Doxomit OD as it does not make you drowsy.
Is it safe?
Yes, but take Doxomit OD only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Doxomit OD for mental disorders.
Interaction between Food and Doxomit OD
Some foods when eaten with Doxomit OD can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Doxomit OD
No research has been done on this till date. Therefore, it is not known what the effect of taking Doxomit OD with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 469
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclegis (doxylamine succinate and pyridoxine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611